四物湯加味方의 항암효과에 대한 실험적 연구
Anti-cancer Effects of Samultang-Gami on HeLa, HepG2, AGS Cells
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: This study was designed to find out the anti-cancer effects of Samultang-Gami which was composed of Rehmanniae Radix(RR), Angelicae Gigantis Radix(AGR), Cnidii Rhizoma(CR), Paeoniae Radix(PR), Cortex Moutan Radicis(CMR), Hedyotis Diffusa(HD) and Caesalpinia Sappan on HeLa, HepG2 and AGS cells. Methods: Various cancer cell lines including HeLa, HepG2 and AGS cells, were used. In vitro anti-cancer effects were measured by MTT assay using cancer cell lines treated with various concentrations of 70% ethanol extract of Samultang-Gami. Expression of cell cycle arrest mediators including Bax, Bcl-2, p53 and DARP-1 proteins were measured by Western blot analysis. Results:1. Samultang-Gami decreased the viability of HeLa and HepG cells in a dose- dependent manner. 2. AGR, CMR, PR and HD decreased the viability of HeLa, HepG2 and AGS cells. 3. We could observe that the decreased Bax and Bcl-2 expression level and the increased PARP-1 expression level by Samultang-Gami extracts treated in HeLa cells. 4. We could observe that the decreased Bcl-2 expression level and the increased Bax, p53 and PARP-1 expression level by RR extracts treated in HeLa cells. and also could observe that the reduction of the protein level of Bcl-2, p53 and PARP-1 and the increase of the protein level of Bax by PR in HeLa cells. 5. We could observe that the increased p53 expression level, the decreased PARP-1's that and the unchanged Bax and Bcl-2's that by Samultang-Gami extracts treated in HepG2 cells. 6. We could observe that the reduced Bcl-2 expression level by each of RR extracts and PR extracts in HepG2 cells. 7. The treatment of Samultang-Gami in AGS cells didn't have any effect on the expression level of Bax, Bcl-2, p53 and PARP-1 . 8. We could observe that the increased p53 and PARP-1 expression level by each of CR, RR and PR extracts in AGS cells. Conclusion: Taken together, we suggest that Samultang-Gami exhibits cytotoxic effects on HeLa, HepG2 and AGS cells, causing apoptosis. The results showed that Samultang-Gami may do so by regulating the expression of specific target molecules that promote efficient apoptotic cell death in a dose-dependent manner.
Abstract
Purpose: This study was designed to find out the anti-cancer effects of Samultang-Gami which was composed of Rehmanniae Radix(RR), Angelicae Gigantis Radix(AGR), Cnidii Rhizoma(CR), Paeoniae Radix(PR), Cortex Moutan Radicis(CMR), Hedyotis Diffusa(HD) and Caesalpinia Sappan on HeLa, HepG2 and AGS cells. Methods: Various cancer cell lines including HeLa, HepG2 and AGS cells, were used. In vitro anti-cancer effects were measured by MTT assay using cancer cell lines treated with various concentrations of 70% ethanol extract of Samultang-Gami. Expression of cell cycle arrest mediators including Bax, Bcl-2, p53 and DARP-1 proteins were measured by Western blot analysis. Results:1. Samultang-Gami decreased the viability of HeLa and HepG cells in a dose- dependent manner. 2. AGR, CMR, PR and HD decreased the viability of HeLa, HepG2 and AGS cells. 3. We could observe that the decreased Bax and Bcl-2 expression level and the increased PARP-1 expression level by Samultang-Gami extracts treated in HeLa cells. 4. We could observe that the decreased Bcl-2 expression level and the increased Bax, p53 and PARP-1 expression level by RR extracts treated in HeLa cells. and also could observe that the reduction of the protein level of Bcl-2, p53 and PARP-1 and the increase of the protein level of Bax by PR in HeLa cells. 5. We could observe that the increased p53 expression level, the decreased PARP-1's that and the unchanged Bax and Bcl-2's that by Samultang-Gami extracts treated in HepG2 cells. 6. We could observe that the reduced Bcl-2 expression level by each of RR extracts and PR extracts in HepG2 cells. 7. The treatment of Samultang-Gami in AGS cells didn't have any effect on the expression level of Bax, Bcl-2, p53 and PARP-1 . 8. We could observe that the increased p53 and PARP-1 expression level by each of CR, RR and PR extracts in AGS cells. Conclusion: Taken together, we suggest that Samultang-Gami exhibits cytotoxic effects on HeLa, HepG2 and AGS cells, causing apoptosis. The results showed that Samultang-Gami may do so by regulating the expression of specific target molecules that promote efficient apoptotic cell death in a dose-dependent manner.
참고문헌 (50)
- Braunwald E, "Harrison's Principles of Internal medicine 16th edition", pp.69~75 (2006), MIP
- Lee JY, "Study on the Mutagenicity of Thermally Oxidized Safflower Oil", J. Korean Soc. Food Sci. Nutr., 29, pp.120~127 (2000)
- Astrow AB, "Rethinking cancer", Lancet, 343, pp.494~495 (1994)
- Chung YT, "Cytotoxic effects of actinomycin D, adramycin and puromycin in the development stage of early mouse embryos", J. Wonkwang Medical Sci., 3, pp.13~34 (1987)
- Cassileth BR, "Contemporary unorthodox treatments in cancer medicine", Annals of Internal Medicine, 101, pp.105~112 (1984)
- 채병주, "위암 환자의 보완대체의학 이용 실태", 대한외과학회지, 72(5), pp.369~378 (2007), 대한외과학회
- 장순복, "우리나라 암 환자가 이용하는 대체⋅보완요법 분류 및 비용분석", pp.22~25 (2005), 보건복지부
- 김봉현, "지황의 법제와 포제법에 관한 문헌적 고찰", 동서의학, 33(3), pp.25~47 (2008)
- 황영명, "生地黃, 乾地黃, 熟地黃이 細胞性免疫反應 및 體液性免疫反應에 미치는 影響", 경희한의대논문집, 10, pp.207~218 (1987)
- 유호진, "수종의 생약이 과화산화수소에 의한 Hypoxanthine-guanine Phosphoribosyl Transferase (HPRT) 유전자 돌연변이 억제에 미치는 효과", 생약학회지, 35(1), pp.28~34 (2004), 한국생약학회
- 김주연, "生地黃이 子宮頸部癌細胞(HeLa cell)에 미치는 影響", 대한한방부인과학회지, 19(1), pp.69~80 (2006), 대한한방부인과학회
- 김성범, "生地黃이 혈관신생, 세포생존 및 염증관련 단백질발현에 미치는 영향", 한방안이비인후피부과학회지, 19(3), pp.22~33 (2006), 대한한방안이비인후피부과학회
- 서형식, "靑黛와 生地黃의 항염 및 항산화 효과에 대한 실험적 연구", 한방안이비인후피부과학회지, 21(3), pp.104~110 (2008), 대한한방안이비인후피부과학회
- 신민교, "임상본초학", pp.385~523 (2000), 영림사
- Namikosi M, "Homoisoflavoids and related compound. IV. Absolute configurations of homoisoflavonoids from caesalpinia sappan L", Chem. Pharm. Bull, 35(9), pp.3579~3602 (1987)
- Park KJ, "Cytotoxic effect of Korean traditional prescription on the human gastric cancer cell lines", Kor. J. Pharmacogn, 28(4), pp.233~238 (1987)
- Kim YS, "Inhibitory effects of herbal medicines on hyaluronidase activity", Kor. J. Pharmocogn, 26(3), pp.265~272 (1995)
- 문연자, "A549 폐암세포주에 대한 蘇木 水抽出物의 세포고사 유도효과", 동의생리병리학회지, 16(3), pp.17~527 (2002), 대한동의병리학회
- Williams GT, "Programmed cell death: apoptosis and oncogenesis", Cell, 65, pp.1097~1098 (1991)
- 常敏毅, "抗癌本草", pp.126~128 (1987), 湖南科學技術出版社
- 김성동, "白花蛇舌草로부터 분리한 ursolic acid의 자연살해효과와 항전이작용", 대전대학교한의학연구소논문집, 5(2), pp.523~533 (1997)
- 송호준, "白花蛇舌草 전탕액 투여가 마우스의 항종양 면역반응에 미치는 영향", 본초분과학회지, 9(1), pp.3~97 (1994)
- 노훈정, "白花蛇舌草 메탄올 추출물의 항종양 효과 및 항암 기전에 관한 연구", 6(1), pp.81~97 (2000)
- 부용출, "녹차와 목단피의 항산화 성분", J. Korean Agric Chem. Soc., 36(5), pp.326~331 (1993)
- 권오근, "목단피 추출물의 항균 및 항산화 작용", Korean J. Postharvest SCL Technol., 5(3), pp.281~285 (1998)
- 손무성, "牡丹皮의 PC12 cell 항산화 효과와 관련 HO, MIF, COMT 유전자 발현에 미치는 영향", 동의생리병리학회지, 17(4), pp.905~913 (2003), 대한동의병리학회
- 김현희, "모단피의 PC12 cell 산화억제 효과 및 neuronal 유전자 발현 profile 분석에 대한 연구", 동의생리병리학회지, 17(2), pp.529~541 (2003), 대한동의병리학회
- 유진균, "목단피 물 추출물의 항산화 및 Tyrosinase 억제효과", 한국식품영양과학회지, 38(3), pp.292~296 (2009), 한국식품영양과학회
- 錢伯文, "腫瘤的辨證施治", pp.1~10 (1980), 上海科學技術出版社
- 郁仁存, "中醫腫瘤學", pp.1~153 (1983), 北京科學出版社
- 賈堃, "癌瘤中醫防治硏究", pp.1~3 (1983), 陝西科學技術出版社
- 배원식, "암의 한ㆍ양방병용치료에 대한 보고", 대한한의학회지, 7(2), pp.53~57 (1986)
- 李岩, "腫瘤學", pp.1~9 (1982), 人民衛生出版社
- 구본홍, "동의내과학", pp.114~115 (1985), 서원당
- 王顯明, "中醫內科辨證學", pp.531~532 (1984), 人民衛生出版社
- 邢雪梅, "抗癌中藥의 生物治療效能硏究近況", 한글판 中醫雜誌, pp.85~90 (1994)
- 이영찬, "파두를 가미한 사군자탕 및 사물탕의 항암효과에 대한 연구", 동의생리병리학회지, 9(1), pp.79~100 (1994)
- Allan DJ, "Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast", J. Pathol., 167, pp.25~32 (1992)
- Wyllie AH, "Apoptosis(The 1992 Frank Rose Memorial Lecture)", Br. J. Cancer, 67, pp.205~208 (1993)
- Middleton G, "Apoptosis in human thymus in sudden and delayed death", Pathology, 26, pp.81~89 (1994)
- Stewart BW, "Mechanisms of apoptosis: intergration of genetic, biochemical, and cellular indicators", J. Natl Cancer Inst, 86, pp.1286~1296 (1994)
- Hockenbery D, "Definding apoptosis", Am J. Pathol, 146, pp.16~19 (1995)
- Eastman A, "Activation of programmed cell death by anticancer agents: cisplatin as a model system", Cancer cells, 2, pp.275~280 (1990)
- Barry MA, "Etoposide-induced apoptosis in human HL-60 cells in associated with intracellular acidification", Cancer Res, 53, pp.2349~2357 (1993)
- Belizario JE, "Cleavage of caspase-1, -3, -6, -8, -9 substrates by protease in skeletal muscles from mice undergoing cancer cachexia", Br J cancer, 84(8), pp.1135~1140 (2001)
- Takashi H, "Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer", Acta Oncologica, 39(4), pp.495~500 (2000)
- Tudor G, "Susceptibility to drug -induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels", Cell Death & Differentiation, 7(6), pp.574~586 (2000)
- Kang M, "Ki-67, p53 and Bcl-2 expression of serrated adenomas of the colon", Am J Surg Pathol, 21(4), pp.417~423 (1997)
- Banasiak KJ, "Mechanisms underlying hypoxia- induced neuronal apoptosis", Progress in Neurobiology, 62, pp.215~249 (2000)
